Between 发表于 2025-3-25 03:26:25

http://reply.papertrans.cn/2/125/12414/12414-21.png

比喻好 发表于 2025-3-25 09:15:40

http://reply.papertrans.cn/2/125/12414/12414-22.png

小臼 发表于 2025-3-25 15:05:36

http://reply.papertrans.cn/2/125/12414/12414-23.png

Cytology 发表于 2025-3-25 15:59:44

Submitted on: 28 July 2002.
Revised on: 20 November 2002.
Accepted on: 18 December 2002.

___________________Indian Journal of Rheumatology

懒惰民族 发表于 2025-3-25 23:23:39

http://reply.papertrans.cn/2/125/12414/12414-25.png

聪明 发表于 2025-3-26 03:54:00

Submitted on: 28 August 2011.
Revised on: 11 November 2011.
Accepted on: 04 January 2012.

___________________Indian Journal of Rheumatology

贸易 发表于 2025-3-26 04:33:58

http://reply.papertrans.cn/2/125/12414/12414-27.png

EVICT 发表于 2025-3-26 10:13:00

http://reply.papertrans.cn/2/125/12414/12414-28.png

画布 发表于 2025-3-26 14:34:49

Submitted on: 05 August 2016.
Revised on: 07 September 2016.
Accepted on: 03 November 2016.

___________________Indian Journal of Rheumatology

Criteria 发表于 2025-3-26 20:40:31

http://reply.papertrans.cn/2/125/12414/12414-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊Indian Journal of Rheumatology 2024/2025影响因子:0.522 (INDIAN J RHEUMATOL) (0973-3698). (RHEUMATOLOGY)(风湿病学)Emerging